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The aim of this study was to determine the causative agent of acute respiratory infection (ARI) in hospitalized children, as well
as investigate the characteristics of ARIs with single and multiple virus detection in two respiratory seasons. In 2010 and 2015,
nasopharyngeal and pharyngeal swabs from a total of 134 children, admitted to the hospital due to ARI, were tested usingmultiplex
PCR. Viral etiology was established in 81.3% of the patients. Coinfection with two viruses was diagnosed in 27.6% of the patients,
and concurrent detection of three or more viruses was diagnosed in 12.8% of the patients. The most commonly diagnosed virus in
both seasons combined was respiratory syncytial virus (RSV) (28.6%), followed by parainfluenza viruses (PIVs) types 1–3 (18.4%),
rhinovirus (HRV) (14.3%), human metapneumovirus (10.1%), adenovirus (AdV) (7.1%), influenza viruses types A and B (4.8%),
and coronaviruses (4.2%). In 2015, additional pathogens were investigated with the following detection rate: enterovirus (13.2%),
bocavirus (HBoV) (10.5%), PIV-4 (2.6%), and parechovirus (1.3%).There were no statistical differences between single andmultiple
virus infection regarding patients age, localization of infection, and severity of disease (𝑃 > 0.05). AdV, HRV, HBoV, and PIVs were
significantly more often detected in multiple virus infections compared to the other respiratory viruses (𝑃 < 0.001).
1. Introduction
Acute respiratory infections (ARIs) are the most common
infections in humans of all ages. Children and infants are
one of the most vulnerable groups of the population, and
ARIs are themost common cause of children’s hospitalization
worldwide [1]. Although bacteria, fungi, and parasites can
cause ARIs, respiratory viruses cause the majority of infec-
tions.Most respiratory virus infections in early childhood are
confined to the upper respiratory tract. About one-third of
infants develop lower respiratory tract infection (LRTI) [2].
The most common causative viral agents of ARIs in children,
respiratory syncytial virus (RSV), human metapneumovirus
(HMPV), influenza viruses (Flu), and adenoviruses (AdV),
were the subject of intensive research for years; therefore,
clinical characteristics and regional epidemiological features
of those ARIs in Croatia are well known [3–6]. However, the
list of respiratory viruses is growing due to the rapid advance
of laboratory diagnostic methods. In the last ten years, newly
discovered viruses have been identified including human
bocavirus (HBoV), coronaviruses NL63 (HCoV-NL63) and
HKU1 (HCoV-HKU1), new enterovirus (HEV), parechovirus
(HPeV), and rhinovirus (HRV) strains [7]. Additionally,
despite the fact that some of the respiratory viruses have been
well known for a long time, particularly parainfluenza type
4 (PIV-4), the technically demanding cultivation methods
and unavailability of commercial tests made it difficult to
diagnose PIV-4’s infection [8, 9]. Infections caused by some
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of the newly discovered viruses (i.e., HBoV, HCoV-NL63,
and HCoV-HKU1) as well as those difficult to cultivate
(PIV-4) have not been recorded in the country yet. There
are few recent studies from the region providing valuable
but still insufficient data regarding regional epidemiology
of infections caused by the abovementioned viruses [10, 11].
Furthermore, the issue of multiple respiratory virus detec-
tion, which occurred because of high sensitivity of molec-
ular methods, complicates the interpretation of laboratory
diagnosis. The aim of this study was to determine the viral
etiology for sixteen viruses tested by multiplex PCR method
among children with ARI admitted to the hospital in Zagreb
region in two respiratory seasons, in order to demonstrate
the need for molecular diagnostics introduced in routine
practice. Also, we aimed to investigate the characteristics
of infections with single and multiple virus detection, espe-
cially regarding the type of virus involved and severity of
infection.
2. Materials and Methods
2.1. Patients and Specimens. A total of 134 children admitted
to Children’s Hospital Zagreb during two winter seasons
(January to March) in 2010 and 2015 with symptoms of
ARI and suspected for viral etiology (normal or slightly
elevated inflammatory markers, i.e., white cell count) were
included in the study. Patients were categorized into three
groups according to age (<1, 1–3, and ≥4 years of age)
and two groups according to the localization of infection
in those with upper respiratory tract infection (URTI)
and lower respiratory tract infection (LRTI). URTI was
defined by symptoms of the common cold, coryza, cough,
and hoarseness often accompanied with fever. Clinical syn-
dromes of respiratory catarrh, rhinitis, and/or pharyngitis are
included in URTI category. LRTI was defined according to
the clinical symptoms of tachypnea, wheeze, severe cough,
breathlessness, and respiratory distress accompanied by LRTI
signs such as nasal flaring, jugular, intercostal, and thoracic
indrawings, rarely cyanosis, and, on auscultation of the chest,
wheeze, crackles, crepitations, and inspiratory rhonchi or
generally reduced breath sounds [2]. Clinical syndromes of
bronchitis, bronchiolitis, and pneumonia were included in
LRTI category. To avoid unnecessary X-ray exposure, chest
radiographs were taken only for some of the patients to
exclude or confirm bacterial pneumonia. Severe disease and
acute respiratory distress syndrome (ARDS) were defined
with need for oxygen supplementation and/or mechanical
ventilation. The patients’ underlying conditions data were
collected retrospectively frommedical charts.Themost com-
mon underlying diseases were asthma, anamnestic recurrent
wheezing episodes, neurological disorders, prematurity, and
anemia. Written consent was obtained from the children’s
parents or caretakers. The study was approved by the
Ethic Committee of the Teaching Institute of Public Health
“Dr. Andrija Stampar.”
Nasopharyngeal and pharyngeal flocked swabs from
each patient were collected, combined, and placed in
viral transport medium (UTM, Copan, Italy). Specimens
accompanied with demographic data and clinical diagnosis
were immediately transported to theMolecularMicrobiology
Laboratory at the Public Health Institute where they were
stored at −80∘C until tested. Nasopharyngeal and pharyngeal
swabs, blood cultures, and serum for serology were searched
to exclude bacterial infection. Patients with samples positive
on bacteriology testing were subsequently excluded from the
study.
2.2. Laboratory Testing. To isolate viral DNA and RNA from
viral transport medium, 200 𝜇L was extracted according to
the manufacturer’s protocol using QIAampMinEluteVirus
Spin Kit (Qiagen, Hilden, Germany). Specimens collected in
2010 were tested usingmultiplex based PCR test for detection
of 12 respiratory viruses, and specimens collected in 2015
were tested for 15 respiratory viruses using Seeplex RV12
and Seeplex RV15 detection kit, respectively (Seegene Inc.,
Seoul, Korea). Briefly, multiplex PCR and cDNA synthesis
was performed in one-step reaction using thermal cycler
GeneAmp 9700 PCR System (Applied Biosystems, Foster
City, USA) followed by microchip electrophoresis detection
on MCE-202 MultiNA device (Shimadzu, Kyoto, Japan)
including software analysis that displays result in form of
electropherogram and virtual gel (Figure 1). Parechovirus
was detected performing real-time RT-PCR using Light-
Mix Modular Parechovirus kit (TIB MOLBIOL, GmbH,
Berlin, Germany) on LightCycler 480 II Instrument (Roche
Diagnostics GmbH, Mannheim, Germany) according to the
manufacturer’s protocol.
Comparison between groups was performed using the
Chi-square test, and statistical analysis was done using
STATISTICA 12.7. 𝑃 < 0.05 was considered significant.
3. Results
There were 62 patients examined and tested in 2010 and 72
patients in 2015, respectively. Patients were one month to
16 years of age with median age 3 ± 3.34 years in 2010 and
3±3.39 years in 2015. Overall, there were 56 girls (41.8%) and
78 boys (58.2%) with female-to-male ratio of 1 : 1.4 (1 : 1.3 in
2010 and 1 : 1.5 in 2015, resp.). Viral etiology was established
in 109 out of 134 (81.3%) patients with ARI (54/62, 87% in
2010; 55/72, 76.4% in 2015, resp.). There were 43 (39.4%)
female and 66 (60.6%) male infected children with female-
to-male ratio of 1 : 1.5. Infected children’s characteristics and
characteristics of infection including number of pathogens
detected, localization, and severity of disease for each season
are presented in Table 1. There were no statistical significant
differences between the two investigated seasons regarding
the abovementioned categories (Table 1). Average length of
hospital stay was 6.2 ± 5.4 days in both seasons.
A single virus was diagnosed in 61.3% (65/109) of the
patients, coinfection with two viruses in 27.6% (30/109)
of the patients, and concurrent detection of three viruses
in 11.0% (12/109) of the patients. There were two cases of
concurrent detection of four viruses (1.8%) one in each of
the investigated seasons. There were no statistical signifi-
cant differences between single and multiple virus infection
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Figure 1: Gel image of electropherogram for (a), (b), and (c) sets of SeeplexRV15OneStepACEDetection test: (L) ladder; (1) sample negative
in sets (a) and (b) and positive for influenza B and enterovirus in set (c); (2) sample positive for human coronavirus 229/NL63 in set (a) and
negative in set (b) and set (c); (3) sample negative in set (a), positive for human coronavirusOC43 in set (b), and positive formetapneumovirus
in set (c); (4) sample negative in sets (a) and (b) and positive for metapneumovirus and enterovirus in set (c). PC: positive control; set
(a) = 859 bp/PCR control, 534 bp/adenovirus, 375 bp/coronavirus 229/NL63, 264 bp/parainfluenza type 2, 189 bp/parainfluenza type 3, and
153 bp/parainfluenza type 1; set (b) = 850 bp/PCR control, 578 bp/coronavirus OC43, 394 bp/rhinovirus, 269 bp/respiratory syncytial virus A,
206 bp/influenza A, and 155 bp/respiratory syncytial virus B; set (c) = 579 bp/bocavirus, 456 bp/influenza B virus, 351 bp/metapneumovirus,
254 bp/parainfluenza virus type 4, 194 bp/enterovirus, and 153 bp/whole process control; NC: negative control.
regarding patients age (𝑃 = 0.0998), localization of infection
(𝑃 = 0.3818), and severity of disease (𝑃 = 0.5147). However,
some of the viruses were significantly more often detected in
multiple infection combination than other viruses. These are
AdV (𝑃 = 0.0013), HRV (𝑃 < 0.0001), PIVs (𝑃 < 0.0001),
and HBoV (𝑃 = 0.0002). Table 2 presents the incidence of
certain viruses and their representation in single infection
and coinfection.
The most commonly diagnosed virus in both seasons
combined was RSV (28.6%; 48/168), followed by PIVs types
1–3 (PIV-3 12.5%, 21/168; PIV-1 3.6%, 6/168; and PIV-2 2.3%,
4/168), HRV (14.3%, 24/168), HMPV (10.1%, 17/168), AdV
(7.1%, 12/168), Flu A+B (4.8%, 8/168), and HCoV (4.2%,
7/168). However, incidence of viruses differs between seasons
(Figure 2). There were no Flu viruses detected in 2010 and
eight of them were detected in 2015 (𝑃 = 0.0014). PIVs
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Table 1: Characteristics of patients with laboratory confirmed viral
respiratory infection in 2010 (𝑁 = 54) and 2015 (𝑁 = 55).
2010 2015
𝑃 value
𝑁 (%) 𝑁 (%)
Gender
Male 31 (57.4) 35 (63.6) 0.5577
Female 23 (42.6) 20 (36.4)
Age (years)
<1 19 (35.2) 22 (40.0)
0.36981–3 26 (48.1) 20 (36.4)
≥4 9 (16.7) 13 (23.6)
Underlying disease
Yes 16 (29.6) 24 (43.6) 0.1128
No 38 (70.4) 31 (56.4)
Hospitalization
Yes 41 (75.9) 45 (81.8) 0.4818
No 13 (24.1) 10 (18.2)
Number of pathogens detected
Single 27 (50.0) 38 (69.1) 0.0516
Multiple 27 (50.0) 17 (30.9)
Localization
URTI 20 (37.0) 22 (40.0)
0.5955LRTI 10 (18.6) 14 (25.4)
URTI + LRTI 24 (44.4) 19 (34.6)
Severity of disease
Mild/moderate 50 (92.6) 49 (89.1) 0.5071
Severe/ARDS 4 (7.4) 6 (10.9)
were significantly more often detected in 2010 than in 2015
(𝑃 = 0.0001) with the highest frequency of PIV-3 detection
in both seasons. Distribution among the types of PIV did not
differ between the seasons (𝑃 = 0.4854).
In 2015, four additional viruses were tested, HEV, HBoV,
PIV-4, and HPeV, revealing the following detection rate in
2015: HEV 13.2%, HBoV 10.5%, PIV-4 2.6%, and HPeV 1.3%,
respectively.
The highest number of all viral infections was diagnosed
in the 1–3-year-old group in both seasons (54.4%, 50/92 in
2010 and 38.2%, 29/76 in 2015) with observed differences in
season’s incidence of PIV andHRV in relation to the age of the
patients (Figure 2). In children below one year of age, higher
incidence of HRV and PIV in 2010 compared to 2015 was
recorded (𝑃 = 0.0092 and 𝑃 = 0.0092, resp.), and in children
1–3 years of age higher incidence of PIV in 2010 than in 2015
(𝑃 = 0.003) was also observed. RSV incidencewas the highest
in 1–3-year-old children in 2010 in contrast to the highest RSV
incidence in <1-year-old group in 2015. However, there were
no statistical differences observed comparing RSV incidence
between the seasons in relation to patients age (𝑃 = 0.426
for <1-year-old group and 𝑃 = 0.062 for 1–3-year-old group,
resp.). HRV was significantly more often detected in children
with URTI (𝑃 = 0.0082), while RSV was significantly more
often detected in children with LRTI (𝑃 < 0.0001) compared
to the other viruses.
4. Discussion
Determining ARIs etiology solely based on symptoms, clin-
ical findings, and biochemical tests without adequate lab-
oratory testing is not possible because pathogen-specific
clinical symptoms are lacking. Establishment of viral etiology
by using traditional methods such as viral cultures is too
slow for clinical purposes and technically laborious. Direct
immunofluorescence assay (DFA) and rapid antigen test yield
results within very few hours, but in many cases they lack
sensitivity and specificity and are available for few viruses
only [12].Therefore, the current gold standard (e.g., viral cul-
ture or DFA) for detecting conventional respiratory viruses
such as Flu, RSV, AdV, and PIVs types 1–3 will be challenged
and eventually replaced by the nucleic acid amplification
techniques (NAATs), which are not routinely performed in
Croatia. Even more, for newly discovered viruses such as
HBoV, NAATs were the only available method for laboratory
diagnosis until recently [13]. Additionally, recently developed
multiplex PCR methods enable testing for many pathogens
in parallel in a single analysis, and commercial tests based on
clinical syndrome approach are available [14]. Viral etiology
in this study was investigated using two multiplex PCR
tests: one with a panel of 12 viruses performed in season
2010 and the new variant of the same test with extended
spectrum of viruses that included detection of HBoV, PIV-4,
and HEV performed in respiratory season 2015.This resulted
with detection of HBoV and PIV-4 in the Croatian children
population for the first time, thus emphasizing the necessity
of using the detection method that will cover all known
respiratory viruses in future diagnostic approach.The perfor-
mance of the used assay always should be considered in inter-
pretation of the result. The characteristics and limitations of
the assay used in this study were the relatively low sensitivity
of 54.17%, but excellent specificity of 98.41, accuracy of
0.96, and agreement with kappa coefficient of 0.81 when
compared to the performance of the Argene/bioMerieux
duplex tests used as gold standard [14]. The limitations of
this observational study also should be noted. They include
relatively small sample size indicating the need for larger
studies to reach more accurate epidemiological data and
precise sampling approach with strictly determined period of
sample collection regarding the onset of ARI that can result
with higher virus detection rate.
The most commonly detected virus in both seasons as
well as important cause of LRTI was RSV that is in line
with the other studies that investigated etiology of ARI in
hospitalized children [15–17]. RSV incidence according to the
children’s ages did not statistically differ between the seasons,
but the typical pattern decrease of RSV detection with
patient’s age was observed in 2015. In 2010, the second and
third most commonly detected viruses were PIV-3 and HRV,
respectively, while in 2015 detection of RSV was followed
by HEV, and both HMPV and HBoV were detected with
equal frequencies. PIV-3 was the most prevalent type of all
PIVs detected in both seasons, which is in accordance with
PIVs type prevalence in other countries [18]. The present
study revealed difference between investigated seasons in
detection of Flu viruses with no Flu viruses detected in 2010
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Table 2: Viral etiology and coinfections identified in 109 infected children in two respiratory seasons.
2010∗ 2015∗∗ Total
𝑁 (single + coinfection) 𝑁 (single + coinfection) 𝑁 (single + coinfection)
AdV 6 (1 + 5) 6 (1 + 5) 12 (2 + 10)
Flu A 0 (0 + 0) 3 (1 + 2) 3 (1 + 2)
Flu B 0 (0 + 0) 5 (4 + 1) 5 (4 + 1)
HCoV 229E/NL63 1 (1 + 0) 2 (1 + 1) 3 (2 + 1)
HCoV OC43/HKU1 2 (0 + 2) 2 (1 + 1) 4 (1 + 3)
HRV 17 (2 + 15) 7 (4 + 3) 24 (6 + 18)
PIV 1 6 (1 + 5) 0 (0 + 0) 6 (1 + 5)
PIV 2 3 (1 + 2) 1 (0 + 1) 4 (1 + 3)
PIV 3 18 (7 + 11) 3 (0 + 3) 21 (7 + 14)
PIV 4 NA 2 (0 + 2) 2 (0 + 2)
RSV A 4 (0 + 4) 8 (6 + 2) 12 (6 + 6)
RSV B 26 (11 + 15) 10 (7 + 3) 36 (18 + 18)
HMPV 9 (3 + 6) 8 (6 + 2) 17 (9 + 8)
HEV NA 10 (5 + 5) 10 (5 + 5)
HBoV NA 8 (1 + 7) 8 (1 + 7)
HPeV∗∗∗ NA 1 (1 + 0) 1 (1 + 0)
Total 92 (27 + 27 cases) 76 (38 + 17 cases) 168 (65 + 44 cases)
NA: not applicable.
∗Diagnosed by RV12 multiplex PCR test.
∗∗Diagnosed by RV15 multiplex PCR test.
∗∗∗Diagnosed by real-time PCR.
and eight Flu strains detected in 2015. Detailed retrospective
data analysis on influence activity provided by WHO collab-
oration centre for influenza surveillance in Croatia showed
that the 2009/2010 season was characterized by an unusual
epidemiological pattern. Peak of incidence was recorded in
autumn and at the end of activity in December of 2009 due
to the emergence of a pandemic strain, and there were no
reported cases at the beginning of 2010. On the contrary, high
activity of influenza was recorded in the beginning of 2015
with influenza peak incidence in February [19]. In this study,
HMPV was detected in 10.1% in both seasons combined,
with no difference between the seasons, which is in line
with published HMPV incidence ranging between 7% and
19% in both hospitalized children and outpatients with ARI
[3, 7]. Although previous studies suggested that HMPV has
been more frequently detected in children with LRTI [6],
this study did not find a difference between HMPV detection
rates according to the localization of infection. Molecular
detection of HRV and HEV revealed the true significance of
these viruses in the etiology of ARI. It seems that HRV and
respiratory HEV are leading causes of upper respiratory tract
infections, butmolecular diagnostic techniques have revealed
the presence of HRV in the lower respiratory tract as well,
and its role in lower airway diseases is increasingly reported
[20]. Results of the present study showed that HRVwas more
frequently detected together with other respiratory viruses,
as well as in children presenting with URTI. There are many
types of HRV and HEV, which disable the use of rapid test
such as DFA, and cultivation is a method of choice only for
those that are easily grown in cell culture, which is not char-
acteristic for many respiratory types of HEVs. HEVs cause
many clinical syndromes. Types of HEVs that cause aseptic
meningitis and febrile illness with or without exanthema
most commonly infect children of preschool and school age
[21]. Half the number of all detected HEVs in this study was
recorded in children under 1 year of age, which indicated
that infections with respiratory types of HEVs appear in early
childhood. In order to investigate as much as possible viral
causes of ARI in the present study, monoplex real-time PCR
forHPeVwas performed in the season 2015, and one infection
was diagnosed in a child <1 year of age. Though frequently
detected in retrospective studies and usually associated with
gastrointestinal and respiratory symptoms, the diagnostics of
HPeVs are still not included in routine screening for acute
diarrhoea or respiratory syndromes. Based on the previous
experience and reports [22], they should be included in
differential diagnosis of respiratory infection even if only in
small children.
This study revealed high coinfection detection rate of
40.4% infections in both seasons combined. Coinfection rates
in two recently published studies from China and Brazil that
search for 18 and 13 respiratory viruses in nasopharyngeal
and pharyngeal secretions of patients with ARI were 18% and
65%, respectively [17, 23]. There were no significant differ-
ences between single and multiple virus infection regarding
patient’s age, localization of infection, and severity of disease.
Recently published meta-analysis also demonstrated that
viral coinfection did not increase severity in all outcomes
assessed (i.e., need of hospitalization, length of stay, need
of supplemental oxygen, intensive care, and mechanical
ventilation) [24]. However, the present study showed that
AdV, HRV, PIVs, and HBoV were significantly more often
6 Journal of Pathogens
60
55
50
45
40
35
30
25
20
15
10
5
0
5
10
15
20
25
30
35
40
45
AdV Flu A+B HCoV HRV PIV RSV HMPV HEV HBoV HPeV
20
10
20
15
Age (years)
%
 o
f d
et
ec
te
d 
vi
ru
se
s
Not tested
<1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4 <1 1–3 ≥4
Figure 2: Viral incidence by patient’s age and viral type in 2010 and 2015.
detected in multiple infection combination than the other
viruses. It seems to be that coinfections are related to the
prolonged period of viral persistence in the mucosa of the
respiratory tract. In particular, HBoV-1 primary infection
is associated with mild respiratory illness with subsequent
prolonged detection of HBoV-1 DNA for up to a year [25].
Broccolo et al. also advocate the hypothesis in which virus
persistence plays a role in the high frequency of coinfections
with proper pathogens of URTI and LRTI [26]. The impor-
tance of recognizing the true respiratory pathogen inmultiple
viral respiratory infection was also emphasized in a meta-
analysis published by Shi et al. It showed strong evidence
for causal attribution of RSV, Flu, PIV, and HMPV in young
children presenting with LRTI compared to asymptomatic
or healthy children, with less strong evidence for HRV, but
no significant difference in the detection of AdV, BoV, or
CoV in cases and controls [27]. Therefore, detected specific
sequences of nucleic acid of HMPV, Flu, PIVs, or RSV in
respiratory specimens enable conclusions about the causative
pathogen, but for the evaluation of the detection of other
pathogens (i.e., HBoV, HCoV, HRV, and AdV) a clinical
evaluation is needed in order to distinguish acute infections
from subclinical events with nucleic acid persistence. Several
studies indicated that symptomatic infections are associated
with higher viral load [28, 29]. Although the multiplex PCR
test used in this study is declared as a qualitative test, there
were differences in the intensity of the virus specific bands
observed in some coinfections, giving the impression that the
virus whose detection has resulted in lower intensity band
was actually present in smaller amounts in the sample (Fig-
ure 1).Therefore, themeasurement of viral load in respiratory
specimen could be possible progress in identifying the true
respiratory pathogen [30].
5. Conclusion
In conclusion, RSV remains the most common but not the
only pathogen among children presenting with ARI, espe-
cially in those under 3 years of age. Multiplex PCR enables
detection of many viruses, and all possible pathogens should
be included in laboratory diagnosis of ARI. Multiple virus
Journal of Pathogens 7
detection still represents the challenge in the interpretation of
the result. Quantitativemolecular diagnosticsmay contribute
to the clarification between coinfection and codetection of
respiratory viral pathogens.
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